Levita Magnetic Grasper Device Safety and Performance Study

Inclusion Criteria: * Patient is between 18 and 60 years of age * Undergoing elective cholecystectomy due to: * Cholelithiasis (Gallbladder stones \< 2.5cm in longer measurement (length or width)) * Gallbladder polyps as assessed by ultrasound * Absence of non-correctable coagulopathy (INR \< 1.4 or, platelet count of \< 50,000/mcl) * Patient has a body mass index (BMI) ≤ 35 kg/m2 and over 20 * Patient, or authorized representative, signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure Exclusion Criteria: * Emergency presentation with acute gallbladder disease * Pancreatitis * Jaundice * Scleroatrophic gallbladder as shown by ultrasound * Biliary tract stones diagnosed before or during surgery * Acute cholecystitis * Gallbladder Empyema * Ongoing peritoneal dialysis * Previous abdominal surgery or laparotomy (presence of any previous upper umbilical incision) * Presence of umbilical hernia or previous umbilical hernia * American Society of Anesthesiologists (ASA) score of III or IV * Patient is undergoing treatment for chronic pain of any origin * Significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure) * Patients with signs of gallbladder perforation diagnosed by ultrasound * Suspicion of biliary cancer * Patients with severe peritonitis * Contraindications to pneumoperitoneum * Known allergy to paracetamol or NSAIDs * Patients with metallic implants (such as pacemakers, prosthesis, etc) * Previously diagnosed or suspected of having a history of choledocholithiasis based on any alterations in plasma hepatic enzymes * Has a biliary tract \> 7mm in size as determined by ultrasound * Has a gallbladder wall thickness that is \> 5mm * Diabetic Blood coagulation issues * Has signs of hepatic endocrinology (i.e: cirrhosis, liver failure, increase in liver enzymes, etc.) * History of endoscopic papillotomy (i.e: Preoperative indication of endoscopic retrograde cholangiopancreatography (ERCP) * Patient is pregnant or wishes to become pregnant during the length of study participation or lactation * Patient is not likely to comply with the follow-up evaluation schedule * Patient is participating in a clinical trial of another investigational drug or device * Patient is mentally incompetent or a prisoner * Known or suspected drug or alcohol abuse * Patient has systemic infection or evidence of any surgical site infection (superficial or organ space) * Patient has compromised immune system or autoimmune disease (WBC \< 4000 or \> 20,000), including prior or pending treatment for HIV or Hep. C * Patient intra-operatively needs an additional surgery while undergoing elective cholecystectomy